In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 13 (1) , 57-61
- https://doi.org/10.1016/0732-8893(90)90055-z
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agentAntimicrobial Agents and Chemotherapy, 1989
- SUSCEPTIBILITY TESTING OF ANAEROBESThe Pediatric Infectious Disease Journal, 1989
- In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338Antimicrobial Agents and Chemotherapy, 1989
- Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococciDiagnostic Microbiology and Infectious Disease, 1989
- Multicenter in vitro evaluation of SM-7338, a new carbapenemAntimicrobial Agents and Chemotherapy, 1989
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1989
- Comparative in-vitro activity of meropenem on clinical isolates from the United KingdomJournal of Antimicrobial Chemotherapy, 1989
- Imipenem (N-formimidoyl thienamycin): In vitro antimicrobial activity and β-lactamase stabilityDiagnostic Microbiology and Infectious Disease, 1985
- In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides sppAntimicrobial Agents and Chemotherapy, 1981
- Simplified Method for Antimicrobial Susceptibility Testing of Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1975